CIS BIO INTERNATIONAL : revenue, balance sheet and financial ratios

CIS BIO INTERNATIONAL is a French company founded 48 years ago, specialized in the sector Enrichissement et retraitement de matières nucléaires. Based in SACLAY (91400), this company of category ETI shows in 2024 a revenue of 129.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CIS BIO INTERNATIONAL (SIREN 312261894)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 129 566 888 € 123 677 914 € 112 220 349 € 109 985 061 € 111 427 392 € 137 302 227 € 129 971 038 € 107 013 398 € 101 851 070 €
Net income -4 642 829 € -3 947 767 € -11 920 829 € -6 070 381 € -8 948 845 € -16 532 327 € -6 737 666 € -9 306 823 € 4 493 172 €
EBITDA -1 227 346 € -6 649 073 € -10 700 880 € -8 809 447 € 43 423 690 € -16 236 663 € -9 861 639 € -16 974 150 € -10 300 149 €
Net margin -3.6% -3.2% -10.6% -5.5% -8.0% -12.0% -5.2% -8.7% 4.4%

Revenue and income statement

In 2024, CIS BIO INTERNATIONAL achieves revenue of 129.6 M€. Revenue is growing positively over 9 years (CAGR: +3.1%). Vs 2023: +5%. After deducting consumption (40.3 M€), gross margin stands at 89.3 M€, i.e. a rate of 69%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -1.2 M€, representing -0.9% of revenue. Positive scissor effect: EBITDA margin improves by +4.4 pts, sign of improved operational efficiency. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -4.6 M€ (-3.6% of revenue), which will impact equity.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

129 566 888 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

89 270 053 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-1 227 346 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-7 991 598 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-4 642 829 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-0.9%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 70%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 27%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 4.2 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 4.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

70.454%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

26.802%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

4.445%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

4.219

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

21.1%

Solvency indicators evolution
CIS BIO INTERNATIONAL

Sector positioning

Debt ratio
70.45 2024
2024
Q1: 0.15
Med: 70.45
Q3: 91.35
Good

In 2024, the debt ratio of CIS BIO INTERNATIONAL (70.45) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
26.8% 2024
2024
Q1: 6.04%
Med: 26.8%
Q3: 47.76%
Good

In 2024, the financial autonomy of CIS BIO INTERNATIONAL (26.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
4.22 years 2024
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 4.01 years
Watch

In 2024, the repayment capacity of CIS BIO INTERNATIONAL (4.22) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 125.76. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

125.757

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-335.407

Liquidity indicators evolution
CIS BIO INTERNATIONAL

Sector positioning

Liquidity ratio
125.76 2024
2024
Q1: 125.76
Med: 284.27
Q3: 464.14
Average

In 2024, the liquidity ratio of CIS BIO INTERNATIONAL (125.76) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-335.41x 2024
2024
Q1: -335.41x
Med: -134.35x
Q3: 16.43x
Average

In 2024, the interest coverage of CIS BIO INTERNATIONAL (-335.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 72 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 91 days. Favorable situation: supplier credit is longer than customer credit by 19 days. Inventory turnover is 54 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 98 days of revenue, i.e. 35.4 M€ to permanently finance. Notable WCR improvement over the period (-71%), freeing up cash.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

35 391 195 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

72 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

91 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

54 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

98 j

WCR and payment terms evolution
CIS BIO INTERNATIONAL

Positioning of CIS BIO INTERNATIONAL in its sector

Comparison with sector Enrichissement et retraitement de matières nucléaires

Valuation estimate

Based on 74 transactions of similar company sales (all years), the value of CIS BIO INTERNATIONAL is estimated at 14 232 176 € (range 9 287 706€ - 32 380 335€). The price/revenue ratio is 0.11x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
74 tx
9287k€ 14232k€ 32380k€
14 232 176 € Range: 9 287 706€ - 32 380 335€
Section all-time Aggregated at NAF section level

Valuation method used

Revenue Multiple
129 566 888 € × 0.11x = 14 232 177 €
Range: 9 287 706€ - 32 380 336€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 74 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Enrichissement et retraitement de matières nucléaires)

Compare CIS BIO INTERNATIONAL with other companies in the same sector:

Voir toutes les statistiques du secteur Enrichissement et retraitement de matières nucléaires

Frequently asked questions about CIS BIO INTERNATIONAL

What is the revenue of CIS BIO INTERNATIONAL ?

The revenue of CIS BIO INTERNATIONAL in 2024 is 129.6 M€.

Is CIS BIO INTERNATIONAL profitable?

CIS BIO INTERNATIONAL recorded a net loss in 2024.

Where is the headquarters of CIS BIO INTERNATIONAL ?

The headquarters of CIS BIO INTERNATIONAL is located in SACLAY (91400), in the department Essonne.

Where to find the tax return of CIS BIO INTERNATIONAL ?

The tax return of CIS BIO INTERNATIONAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CIS BIO INTERNATIONAL operate?

CIS BIO INTERNATIONAL operates in the sector Enrichissement et retraitement de matières nucléaires (NAF code 20.13A). See the 'Sector positioning' section above to compare the company with its competitors.